| 1. | researcher17 | |
| 2. | lakehome45 | |
| 3. | ggordon100 | |
| 4. | SPICKS100 | |
| 5. | umberjacques |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | umberjacques 10/17/2017 Top Analyst likes it.... |
| 2. | researcher17 09/25/2017 long haul individuals, long haul. Disregard the reality administration dumped shares a week ago and around 18% prior |
| 3. | ggordon100 09/25/2017 would you be able to present at a meeting if your organization's stock cost was down just about 20% |
| 4. | lakehome45 09/25/2017 Hard couple of days |
| 5. | lakehome45 02/07/2018 Announces updated data from expansion cohorts in a phase 1 trial of cabozantinib in combination with either … |
| 6. | researcher17 10/17/2017 Positive study results and regulatory news and still could not hold onto gains. Maybe consolidation for a while? {Image} |
| 7. | lakehome45 10/17/2017 NEWS: Exelixis Rockets To 17-Year High On Kidney, Liver Cancer News |
| 8. | researcher17 03/15/2018 Company has completed the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug… |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Exelixis, Inc.
- EXEL
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.